Sponsored by:

Duke MMIL designs novel SPECT/CT system for 3D breast imaging

Jul 17, 2007
2007 07 17 14 38 39 706
2007 07 17 14 38 39 706
Image courtesy of Duke University Medical Center Multi-Modality Imaging Lab.

Latest in Molecular Imaging
Patient examples of SPECT/CT and PET/CT RECIP 1.0. (A) SPECT and PET maximum-intensity projection (MIP) images in 74-year-old man with mCRPC. Serum PSA level at baseline was 449 ng/mL and slightly increased to 525 ng/mL after two cycles of Lu-177 PSMA. Eastern Cooperative Oncology Group (ECOG) score was 2 at baseline and increased to 3 after 2 cycles. The patient was classified by readers as RECIP-progressive disease on both SPECT and PET. Overall survival was 4.7 months. Two cycles of Lu-177 PSMA were administered. (B) SPECT and PET MIP images in 74-year-old man with mCRPC. Serum PSA level was 231 ng/mL at baseline and decreased to 12.5 ng/mL after 2 cycles of Lu-177 PSMA. ECOG score was less than 2 at baseline and after 2 cycles of Lu-177 PSMA. The patient was classified by readers as RECIP-partial response on both SPECT and PET. Overall survival was 14.3 months. Four cycles of Lu-177 PSMA were administered.
SPECT/CT predicts overall survival in Pluvicto patients
April 25, 2025
Imaging Life Issue 20 now available
Sponsored
Imaging Life Issue 20 now available
April 1, 2025
Manufacturing Facility Process
Eckert & Ziegler signs manufacturing deal with Pentixapharm
April 24, 2025
Murr
UM launches new research reactor with $10M deal
April 23, 2025
Related Stories
2007 07 17 15 08 50 706
Molecular Imaging
Duke MMIL designs novel SPECT/CT system for 3D breast imaging
2007 07 17 14 32 28 706
Molecular Imaging
Duke MMIL designs novel SPECT/CT system for 3D breast imaging
2007 06 25 10 54 15 706
Molecular Imaging
Studies link Alzheimer's to beta-amyloid and potential for new ligand
Imaging Life Issue 20 now available
Sponsor Content
Imaging Life Issue 20 now available
More in Molecular Imaging
SPECT/CT predicts overall survival in Pluvicto patients
By Will Morton
New evidence supports using SPECT/CT scans along with serum PSA levels to evaluate early patient responses to Pluvicto treatment.
April 25, 2025
Patient examples of SPECT/CT and PET/CT RECIP 1.0. (A) SPECT and PET maximum-intensity projection (MIP) images in 74-year-old man with mCRPC. Serum PSA level at baseline was 449 ng/mL and slightly increased to 525 ng/mL after two cycles of Lu-177 PSMA. Eastern Cooperative Oncology Group (ECOG) score was 2 at baseline and increased to 3 after 2 cycles. The patient was classified by readers as RECIP-progressive disease on both SPECT and PET. Overall survival was 4.7 months. Two cycles of Lu-177 PSMA were administered. (B) SPECT and PET MIP images in 74-year-old man with mCRPC. Serum PSA level was 231 ng/mL at baseline and decreased to 12.5 ng/mL after 2 cycles of Lu-177 PSMA. ECOG score was less than 2 at baseline and after 2 cycles of Lu-177 PSMA. The patient was classified by readers as RECIP-partial response on both SPECT and PET. Overall survival was 14.3 months. Four cycles of Lu-177 PSMA were administered.
PET scans identify people at early risk for cognitive decline
By Will Morton
Amyloid PET scans in people with early signs of Alzheimer’s can identify those at higher risk of progressing to cognitive decline.
April 24, 2025
Ad Voxels Thumbnail
Eckert & Ziegler signs manufacturing deal with Pentixapharm
By AuntMinnie.com staff writers
Eckert & Ziegler Radiopharma GmbH has signed a manufacturing agreement with Pentixapharm.
April 24, 2025
Manufacturing Facility Process
UM launches new research reactor with $10M deal
By AuntMinnie.com staff writers
The University of Missouri (UM) has inked a $10 million deal with a Korean consortium.
April 23, 2025
Murr
Shine Technologies, Modawina Medical sign UAE distribution deal
By AuntMinnie.com staff writers
Shine Technologies has signed an agreement with Modawina Medical Company to distribute Shine’s lutetium-177 isotope in the UAE.
April 22, 2025
Atom Nuclear Lab 400
Combined PET scans predict the progression of Alzheimer’s disease
By Will Morton
Combining information from amyloid PET and FDG-PET scans can predict progression from mild cognitive impairment to Alzheimer's.
April 21, 2025
Ad Pet Fdg Thumbnail
PET scans predict outcomes for patients undergoing CAR T-cell therapy
By Will Morton
PET scans performed at one or three months after patients with large B-cell lymphoma begin CAR T-cell therapy can indicate whether they are responding to the treatment.
April 18, 2025
Pet Scan Patient
New theranostics PET tracer shows promise
By Will Morton
A new gallium-68 (Ga-68) PET/CT radiotracer appears superior over F-18 FDG for detecting bone metastases.
April 17, 2025
Images of a 69-year-old man diagnosed with prostate cancer who had a history of endocrine therapy for two years. (a) The maximum intensity projection (MIP) image of F-18 FDG showed moderate radiotracer uptake in a thoracic vertebra. (e) The MIP image of Ga-68 DOTA-IBA demonstrated more lesions in the cervical vertebra and pelvis. (b) An osteoblastic lesion in the C3 vertebra right attachment (curved arrows) was negative on F-18 FDG (SUVmax = 2.0) and positive on Ga-68 DOTA-IBA (SUVmax = 8.7). (c) Another osteoblastic lesion in the T10 vertebra left side (arrowheads) was both positive on F-18 FDG (SUVmax = 5.2) and positive on Ga-68 DOTA-IBA (SUVmax = 35.0). (d) Osteoblastic lesions in bilateral ilium (dotted arrows and arrows) were negative on F-18 FDG (left: SUVmax = 1.4, right: SUVmax = 1.6) and positive on Ga-68 DOTA-IBA (left: SUVmax = 7.6, right: SUVmax = 8.7). Follow-up imaging three months later confirmed the presence of these bone metastases. Image and caption available for republishing under Creative Commons license (CC BY 4.0 DEED, Attribution 4.0 International) and courtesy of Scientific Reports.
PET/CT detects vasculitis following COVID-19 vaccination
By Will Morton
A whole-body F-18 FDG-PET/CT scan was key in identifying medium-vessel vasculitis in a patient following a Moderna COVID-19 vaccination.
April 11, 2025
Covid 19 Vax Thumbnail
PET links depressive symptoms to Alzheimer’s brain pathology
By Will Morton
Researchers have reported that worsening depression in older adults is related to higher levels of Alzheimer’s pathology.
April 10, 2025
A Dpatient
IMV: PET procedure volumes continue strong growth trend
By Davin Korstjens
Overall PET procedure volumes increased by 12.2% in 2024, according to the IMV 2025 PET Market Summary Report.
April 10, 2025
Graph Arrow Up
Having a father with Alzheimer's could mean higher risk of the disease
By Kate Madden Yee
Having a father with Alzheimer's may be tied to a greater spread of the tau protein in the brain, researchers have reported.
April 9, 2025
Alzheimers Tau
Page 1 of 603
Next Page